# NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
> **NDA215457** · New Drug Application · Sponsor: KALEO INC · Approved 2022-02-28
## Drug
- **FDA Application Number:** NDA215457
- **Application type:** New Drug Application
- **Brand name:** NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** KALEO INC
- **Manufacturer:** Kaleo, Inc.
- **First approval:** 2022-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215457)
---
*MORVS · CC0 1.0*